Phase II trial of 4-demethoxydaunorubicin in patients with advanced malignant melanoma Journal Article


Authors: Stanton, G.; Casper, E. S.; Friedman, B.
Article Title: Phase II trial of 4-demethoxydaunorubicin in patients with advanced malignant melanoma
Keywords: adult; cancer chemotherapy; clinical article; aged; drug efficacy; antineoplastic agents; melanoma; phase 2 clinical trial; leukopenia; nausea; stomatitis; vomiting; gastrointestinal toxicity; daunorubicin; idarubicin; drug therapy; adverse drug reaction; mouth; therapy; intravenous drug administration; hematologic diseases; middle age; bone marrow depression; drug evaluation; intoxication; human; male; female; priority journal; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; blood and hemopoietic system
Journal Title: Cancer Treatment Reports
Volume: 69
Issue: 7-8
ISSN: 0361-5960
Publisher: National Cancer Institute  
Date Published: 1985-07-01
Start Page: 915
End Page: 916
Language: English
PUBMED: 3860298
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 26 October 2021 -- Source: Scopus
Citation Impact
MSK Authors
  1. Ephraim S Casper
    108 Casper